JKA...so there are some advantages to being in suspension (price can't go down), whilst they mull over the next deal.Took October off, so haven't been following the market closely.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025